Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Scott Pearsall?

Scott Pearsall

Senior Director

ACCELERON PHARMA INC

HQ Phone:  (617) 649-9200

Direct Phone: (617) ***-****direct phone

Email: s***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

ACCELERON PHARMA INC

128 Sydney Street

Cambridge, Massachusetts,02139

United States

Company Description

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases. Its pioneering research platform leverages the powerful biology behind the body's... more.

Find other employees at this company (189)

Web References(13 Total References)


www.newsrx.com

Data presented on September 17, 2006 by Scott Pearsall, PhD, director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


www.bio.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


www.acceleronpharma.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


www.acceleronpharma.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


www.acceleronpharma.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory